ClinicalTrials.gg
Not yet recruitingNCT07748052Updated Aug 5, 2026

Strength Training Combined With Blood Flow Restriction and Cerebral Palsy

An interventional study of strength training combined with blood flow restriction and designed physical therapy program and a specially designed physical therapy program in Cerebral Palsy, sponsored by Cairo University. Not yet recruiting. Open to participants aged 4 Years to 10 Years. Per ClinicalTrials.gov, last updated 2026-08-05.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
4 Years to 10 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 114 studies in Cerebral Palsy by Cairo University — 28 open to participants now, 34 under way, 1 of them phase 3. Cerebral Palsy · Cairo University.

Planned enrollment
91st of 94
26 · median 40
Started
2026
with 17 others
No phase
93 of 114
23 open now
Primary completion
2027-02
later than 30 of 33 live
Registered
112th of 114
by date

Among the 114 studies in Cerebral Palsy by Cairo University, this one is the 91st largest by planned enrollment of the 94 interventional ones that give a count, is one of 18 that started in 2026, is one of 93 with no phase, reaches primary completion later than 30 of the 33 other live ones, and was the 112th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

28 of the 114 studies in Cerebral Palsy by Cairo University are open now, in 1 country. Recruiting first, the newest first:

22 more — sign in →

By country, each count listing its studies:

All 28 open studies →

Where they have run

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 4 Years to 10 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 114 studies in Cerebral Palsy by Cairo University, or all of them as a file.
02

Study summary

load resistance exercises are performed while partially restricting venous blood flow to the exercising limb using a pneumatic cuff. In children with hemiplegic cerebral palsy, this intervention has been proposed to enhance muscle strength and hypertrophy while minimizing mechanical stress on joints and soft tissues. Previous studies suggest that BFR training may improve muscle thickness, muscle strength, functional mobility, gait performance, and overall physical function compared with conventional low-intensity strength training alone. However, careful monitoring of cuff pressure, exercise intensity, and safety considerations is essential when applying this technique in pediatric populations.

03

Conditions studied

  • Cerebral Palsy

Browse trials for

Keywords

  • cerebral palsy
  • progressive resistive exercise
  • low load resistive training
  • blood flow restriction
04

Who can participate

Ages eligible
4 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. A diagnosis of spastic hemiplegic CP
  2. Degree of spasticity ranges from 1+ and 2, according to modified Ashworth scale (MAS)
  3. The age of the selected children will range from 4 to 6 years old.
  4. Children are levels II and III according to GMFCS

Exclusion criteria

Exclusion Criteria:

1- Children with visual or auditory problems. 2. Children with severe intellectual disability (IQ less than 65 according to Stanford Binet intelligence scale).

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
26 participants (estimated)

Study arms

  • Experimental
    strength training combined with blood flow restriction and designed physical therapy program

    Other: strength training combined with blood flow restriction and designed physical therapy program

  • Experimental
    designed physical therapy program

    Other: a specially designed physical therapy program

Interventions

  • Otherstrength training combined with blood flow restriction and designed physical therapy program

    A specially designed physical therapy program in addition to progressive resistive exercises for 60 min (30 min designed P.T program and other 30 min for progressive resistive exercise with blood flow restriction ), 3 sessions/ week for 6 successive weeks. strengthening exercise for shoulder flexors, abductors and external rotators, elbow flexors and extensors will be applied with low load while blood flow restriction is applied proximal to the limb

  • Othera specially designed physical therapy program

    conventional physical therapy program including reinforcement of the normal motor development, reflex inhibiting patterns, postural reaction, stretching, strengthening exercises, and gait training was applied to children in the control group

06

What researchers measure

Primary outcomes

  1. ultrasonography for measuring muscle thickness

    Time frame: 6 weeks

  2. quality of upper-extremity skills test for measuring upper limb function

    Time frame: 6 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Feb 2027, 5 months later.

Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 5 months is below that.

Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 30, 2026
First posted
Aug 5, 2026
StartEst.
Aug 6, 2026
Primary completionEst.
Feb 1, 2027
CompletionEst.
Jul 11, 2027
Last update
Aug 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07748052
Lead sponsor
Cairo University
Responsible party
Alaa Fahmy Hassan Al Nemr (assistant professor at faculty of physical therapy, cairo university, Cairo University) — Principal investigator
First posted
Aug 5, 2026
Start date
Aug 6, 2026 (estimated)
Primary completion
Feb 1, 2027 (estimated)
Completion
Jul 11, 2027 (estimated)
Last update
Aug 5, 2026

Study contacts

Alaa Alnemr
Contact
alaaalnemr28@gmail.com
+201003727467

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion